Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Robert M. Henshaw is active.

Publication


Featured researches published by Robert M. Henshaw.


Clinical Orthopaedics and Related Research | 1999

Cryosurgery in the treatment of giant cell tumor: A long term followup study

Martin M. Malawer; Jacob Bickels; Isaac Meller; Richard G. Buch; Robert M. Henshaw; Yehuda Kollender

Between 1983 and 1993, 102 patients with giant cell tumor of bone were treated at three institutions. Sixteen patients (15.9%) presented with already having had local recurrence. All patients were treated with thorough curettage of the tumor, burr drilling of the tumor inner walls, and cryotherapy by direct pour technique using liquid nitrogen. The average followup was 6.5 years (range, 4-15 years). The rate of local recurrence in the 86 patients treated primarily with cryosurgery was 2.3% (two patients), and the overall recurrence rate was 7.9% (eight patients). Six of these patients were cured by cryosurgery and two underwent resection. Overall, 100 of 102 patients were cured with cryosurgery. Complications associated with cryosurgery included six (5.9%) pathologic fractures, three (2.9%) cases of partial skin necrosis, and two (1.9%) significant degenerative changes. Overall function was good to excellent in 94 patients (92.2%), moderate in seven patients (6.9%), and poor in one patient (0.9%). Cryosurgery has the advantages of joint preservation, excellent functional outcome, and low recurrence rate when compared with other joint preservation procedures. For these reasons, it is recommended as an adjuvant to curettage for most giant cell tumors of bone.


Cancer | 2000

The percutaneous needle biopsy is safe and recommended in the diagnosis of musculoskeletal masses.

James A. Welker; Robert M. Henshaw; James Jelinek; Barry Shmookler; Martin M. Malawer

The purpose of this study was to analyze the role of percutaneous core needle biopsy in the diagnosis of musculoskeletal sarcomas.


Clinical Orthopaedics and Related Research | 2002

Distal femur resection with endoprosthetic reconstruction: a long-term followup study.

Jacob Bickels; James C. Wittig; Yehuda Kollender; Robert M. Henshaw; Kristen L. Kellar-Graney; Issac Meller; Martin M. Malawer

The distal femur is a common site for primary and metastatic bone tumors and therefore, it is a frequent site in which limb-sparing surgery is done. Between 1980 and 1998, the authors treated 110 consecutive patients who had distal femur resection and endoprosthetic reconstruction. There were 61 males and 49 females who ranged in age from 10 to 80 years. Diagnoses included 99 malignant tumors of bone, nine benign-aggressive lesions, and two nonneoplastic conditions that had caused massive bone loss and articular surface destruction. Reconstruction was done with 73 modular prostheses, 27 custom-made prostheses, and 10 expandable prostheses. Twenty-six gastrocnemius flaps were used for soft tissue reconstruction. All patients were followed up for a minimum of 2 years. Function was estimated to be good or excellent in 94 patients (85.4%), moderate in nine patients (8.2%), and poor in seven patients (6.4%). Complications included six deep wound infections (5.4%), six aseptic loosenings (5.4%), six prosthetic polyethylene component failures (5.4%), and local recurrence in five of 93 patients (5.4%) who had a primary bone sarcoma. The limb salvage rate was 96%. Distal femur endoprosthetic reconstruction is a safe and reliable technique of functional limb sparing that provides good function and local tumor control in most patients.


Clinical Orthopaedics and Related Research | 2000

Reconstruction of hip stability after proximal and total femur resections.

Jacob Bickels; Isaac Meller; Robert M. Henshaw; Martin M. Malawer

Dislocation is the most common complication after proximal and total femur endoprosthetic reconstruction. The current study describes a surgical technique of acetabular preservation and reconstruction of the joint capsule and abductor mechanism that recreates joint stability and avoids dislocation. Between 1980 and 1996, 57 patients underwent proximal or total femur resection with endoprosthetic reconstruction. Forty-six patients had primary sarcoma of bone, nine had other bone tumors, and two had metabolic bone disease. The acetabulum was spared and not resurfaced in all patients. Bipolar hemiarthroplasty was performed in 49 patients, and fixed unipolar hemiarthroplasty was performed in eight. Soft tissue reconstruction included Dacron tape capsulorrhaphy over the prosthetic neck, reattachment of the abductor mechanism to the prosthesis, and extracortical bone fixation. The average followup period was 6.5 years (range, 2-18.2 years). Dislocation occurred in only one (1.7%) patient, and aseptic prosthetic loosening occurred in three (5.3%) patients. Four patients with primary bone sarcoma had local recurrence, of whom one required amputation of the limb. The limb salvage rate was 98%. Eighty-one percent of the patients had a good to excellent functional outcome. Acetabular preservation, capsulorrhaphy, and reconstruction of the abductor mechanism recreate hip stability and avoid dislocation after proximal and total femur endoprosthetic reconstruction.


Spine | 1999

Extraspinal Bone and Soft-tissue Tumors as a Cause of Sciatica: Clinical Diagnosis and Recommendations: Analysis of 32 Cases

Jacob Bickels; Neil Kahanovitz; Cynthia K. Rubert; Robert M. Henshaw; David P. Moss; Isaac Meller; Martin M. Malawer

STUDY DESIGN Between 1982 and 1997, the authors treated 32 patients with sciatica who subsequently were found to have a tumor along the extraspinal course of the sciatic nerve. SUMMARY OF BACKGROUND DATA Extraspinal compression of the sciatic nerve by a tumor is a rare cause of sciatica. Signs and symptoms overlap those of the more common causes of sciatica (i.e., herniated disc and spinal stenosis). OBJECTIVE To characterize the unique clinical presentation of these patients and to formulate guidelines that may lead to early diagnosis. METHODS All pertinent clinical data and studies were reviewed retrospectively, and standard demographic data were collected for analysis. RESULTS These patients typically sought treatment for an insidious onset of sciatic pain that was constant, progressive, and unresponsive to change in position or bed rest. The mean time to final diagnosis was 11.9 months (median, 6 months). Seventeen patients were able to locate their pain to a specific point along the extraspinal course of the sciatic pain, and a mass was noted in 13 patients. Eighteen of these tumors were in the pelvis, 10 in the thigh, and 4 in the popliteal fossa and calf. CONCLUSIONS A high index of clinical suspicion is the key to early diagnosis of bone or soft-tissue tumors as a cause of sciatica; special attention should be given to pain pattern, physical examination of the entire course of the sciatic nerve, and selection of proper imaging studies. Routine anteroposterior plain radiography of the pelvis as part of the initial imaging screening process is recommended.


Clinical Orthopaedics and Related Research | 1996

Delayed reduction of traumatic knee dislocation. A case report and literature review.

Robert M. Henshaw; Matthew S. Shapiro; William L. Oppenheim

Knee dislocation after high energy trauma poses a major challenge to patients and treating physicians. The case presented documents the history and treatment of an unreduced posterior knee dislocation discovered 24 weeks after injury. Delayed surgical reduction was achieved, and satisfactory results were obtained with 22 months of followup of the patient. A detailed review of the literature found no comparable examples of longstanding traumatic dislocations of the knee but shed light on the probable cause for this unusual case. Close clinical followup, even after appropriate initial treatment of knee dislocations, is needed to eliminate similar occurrences.


Journal of Bone and Joint Surgery, American Volume | 2013

Long-Term Results of Intralesional Curettage and Cryosurgery for Treatment of Low-Grade Chondrosarcoma

Morteza Meftah; Patricia Schult; Robert M. Henshaw

BACKGROUND Data regarding outcomes following intralesional curettage and cryosurgical treatment of low-grade chondrosarcoma of bone are limited. The aim of this study was to assess the long-term oncologic and functional outcomes of two different cryosurgery techniques. METHODS Forty-three low-grade chondrosarcoma lesions (in forty-two patients) were treated with intralesional curettage and cryosurgery from June 1983 to October 2006. Eleven lesions were treated with cryoprobes and thirty-two were treated with the modified direct-pour Marcove technique. The mean patient age was 44.9 ± 11.3 years (range, 21.8 to 66.4 years), and the mean duration of follow-up was 10.2 ± 4.6 years (range, five to 22.5 years). Indications for treatment included a radiographic appearance consistent with a cartilage tumor with evidence of aggressive behavior. Pearson correlation and multivariate analyses were used to evaluate the relationships between predictive factors (including lesion size, soft-tissue extension, and location, patient age, cortical erosion, and presence of preoperative pain) and outcomes. RESULTS The mean overall Musculoskeletal Tumor Society (MSTS) score was 26.5 ± 3.1 (range, 17 to 30). There were four local recurrences, all in patients who had had tumor extension out of the bone with soft-tissue involvement at initial presentation. The mean time to recurrence was 2.4 ± 2.3 years (range, 0.6 to 5.6 years). No patients developed metastatic disease during the follow-up period. There were no differences between the cryoprobe and Marcove techniques with respect to the MSTS score, fracture, or local recurrence. A significant correlation between tumor recurrence and soft-tissue extension was found (r = 0.79). Kaplan-Meier survivorship, with freedom from recurrence as the end point, was 90.7%. CONCLUSIONS Intralesional curettage and cryosurgery for low-grade chondrosarcoma is safe and effective in selected patients. The presence of preoperative cortical breakthrough and soft-tissue extension was the strongest predictor of local recurrence following use of this technique. LEVEL OF EVIDENCE Therapeutic level IV. See instructions for authors for a complete description of levels of evidence.


Journal of Arthroplasty | 1993

High Assembly Strains and Femoral Fractures Produced During Insertion of Uncemented Femoral Components A Cadaver Study

Murali Jasty; Robert M. Henshaw; Daniel O. O'Connor; Dilliam H. Harris

The assembly strains produced in cadaver femurs during uncemented femoral arthroplasty were measured using strain gages and photoelastic coatings. Resecting the femoral neck, reaming the canal with power drills, and rasping with an optimal size rasp, as determined by preoperative radiographic templating, produced small assembly strains, up to 300 microstrain. Insertion of an optimal-size prosthesis after preparing the femoral canal with instruments the same size as the prosthesis produced moderate assembly strains, up to 1,000 microstrain. Half a millimeter press-fit of optimal prostheses produced larger assembly strains, up to 2,000 microstrain. Half a millimeter press-fit of a prosthesis that was also one size (1.0 mm) larger than that determined to be optimum produced even larger assembly strains (2,000-6,000 microstrain) and longitudinal linear fractures in the femoral cortex. Insertion of prostheses that were smaller than the rasps produced minimal strains in the femoral cortex. The magnitude of peak strains produced by press-fitting the femoral components and the small amounts of disparity between the size of the recess and the prosthesis necessary to produce these strains show the narrow range of tolerances available to the surgeon. Cementless femoral arthroplasty requires great care in preparing the femoral canal to the appropriate size as determined from preoperative templating, using accurate and precisely toleranced instrumentation and prosthetic components in order to avoid femoral fractures, yet obtain a stable fit.


Journal of Arthroplasty | 2008

Implant Design and Resection Length Affect Cemented Endoprosthesis Survival in Proximal Tibial Reconstruction

Chia-Chun Wu; Robert M. Henshaw; Tamir Pritsch; Malcolm H. Squires; Martin M. Malawer

Endoprosthetic reconstruction of the proximal tibia continues to pose many challenges. A retrospective analysis of 44 consecutive patients who underwent cemented proximal tibial replacement were included to investigate if patient age, surgical stage, type of implant, stem diameter, or resection length could be associated with implant failure. Fifteen patients (34%) suffered prosthetic failure, 7 due to infection. Prosthetic-related complications occurred in 13 patients (30%). Custom design prosthesis and longer length of resection were significantly associated with prosthesis survival in a Cox regression analysis (P = .001, hazard ratio = 8.747 and P = .044, hazard ratio = 1.217, respectively). Cemented proximal tibial replacement offers a functional knee, but reducing risk of complications still remains challenging. Prosthetic design and length of resection affect overall cemented endoprosthesis survival.


Archive | 2004

Review of Endoprosthetic Reconstruction in Limb-sparing Surgery

Robert M. Henshaw; Martin Malawer

Endoprosthetic replacement of segmental skeletal defects is the preferred technique of reconstruction after resection of bone sarcomas. Today, all of the major anatomic joints with their adjacent segmental bone can be reconstructed safely and reliably with a modular endoprosthetic replacement. Prosthetic reconstruction is routinely performed for the proximal femur, distal femur, total femur, proximal tibia, proximal humerus, and scapula. Allografts are rarely used.

Collaboration


Dive into the Robert M. Henshaw's collaboration.

Top Co-Authors

Avatar

Martin M. Malawer

George Washington University

View shared research outputs
Top Co-Authors

Avatar

Martin Malawer

MedStar Washington Hospital Center

View shared research outputs
Top Co-Authors

Avatar

Jacob Bickels

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

Isaac Meller

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

James A. Welker

MedStar Washington Hospital Center

View shared research outputs
Top Co-Authors

Avatar

James S. Jelinek

MedStar Washington Hospital Center

View shared research outputs
Top Co-Authors

Avatar

Yehuda Kollender

Tel Aviv Sourasky Medical Center

View shared research outputs
Top Co-Authors

Avatar

Barry M. Shmookler

MedStar Washington Hospital Center

View shared research outputs
Top Co-Authors

Avatar

Barry Shmookler

Washington Cancer Institute

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge